Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2025)

Mangoceuticals' Other Accumulated Expenses history spans 2 years, with the latest figure at $160684.0 for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 57.15% year-over-year to $160684.0; the TTM value through Sep 2025 reached $160684.0, down 57.15%, while the annual FY2024 figure was $373000.0, N/A changed from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $160684.0 at Mangoceuticals, roughly flat from $160684.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $400000.0 in Q2 2024 and bottomed at $160684.0 in Q2 2025.